Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.19% Nasdaq Down0.22%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
7.16 Up 0.07(0.92%) 10:10AM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Research ReportsGet Research Reports for:
Recent Reports
ReleasedContributorAuthorTitlePagesPrice
Apr 16, 2014Pechala's ReportsLubomir PechalaARIAD PHARMACEUTICALS INC (ARIA) - REPORT FOR ACTIVE TRADERS1$25
Apr 16, 2014ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for ARIA11$25
Apr 16, 2014ValuEngine, Inc.N/AValuEngine Industry Report for Medical-drugs18$49
Apr 16, 2014New Constructs, LLCN/AARIA: Due Diligence Review: Forensic Earnings and Valuation5$25
Apr 11, 2014S&P Capital IQ Quantitative ReportN/AARIAD Pharmaceuticals11$126.50
Apr 11, 2014Wright ReportsN/AWright Investors Service Comprehensive Report for Ariad Pharmaceuticals Incorporated42$75
Apr 11, 2014Pechala's ReportsFrantisek PechalaARIAD PHARMACEUTICALS INC (ARIA) 12-months forecast1$15
Apr 10, 2014Ford Investor Services, Inc.N/AIndustry Value Graph: AEGR , AGIO , ARIA , HSKA , OSUR , PTX , PRPH -- DRUGS3$34.50
Apr 10, 2014Ford Investor Services, Inc.N/AValue Graph: ARIAD PHARMACEUT -- ARIA1$11.50
Apr 10, 2014Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ARIAD PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20

View All Reports for ARIA ...